Application of a Novel Score Test for Genetic Association Incorporating Gene-Gene Interaction Suggests Functionality for Prostate Cancer Susceptibility Regions

Aims: We introduce an innovative multilocus test for disease association. It is an extension of an existing score test that gains power over alternative methods by incorporating a parsimonious one-degree-of-freedom model for interaction. We use our method in applications designed to detect interactions that generate hypotheses about the functionality of prostate cancer (PRCA) susceptibility regions. Methods: Our proposed score test is designed to gain additional power through the use of a retrospective likelihood that exploits an assumption of independence between unlinked loci in the underlying population. Its performance is validated through simulation. The method is used in conditional scans with data from stage II of the Cancer Genetic Markers of Susceptibility PRCA genome-wide association study. Results: Our proposed method increases power to detect susceptibility loci in diverse settings. It identified two high-ranking, biologically interesting interactions: (1) rs748120 of NR2C2 and subregions of 8q24 that contain independent susceptibility loci specific to PRCA and (2) rs4810671 of SULF2 and both JAZF1 and HNF1B that are associated with PRCA and type 2 diabetes. Conclusions: Our score test is a promising multilocus tool for genetic epidemiology. The results of our applications suggest functionality for poorly understood PRCA susceptibility regions. They motivate replication study.

[1]  Matti Pirinen,et al.  A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 , 2010, Nature Genetics.

[2]  G. Church,et al.  Modular epistasis in yeast metabolism , 2005, Nature Genetics.

[3]  Faming Liang,et al.  Efficient p-value evaluation for resampling-based tests. , 2011, Biostatistics.

[4]  C R Weinberg,et al.  Designing and analysing case-control studies to exploit independence of genotype and exposure. , 1997, Statistics in medicine.

[5]  P. Donnelly,et al.  Genome-wide strategies for detecting multiple loci that influence complex diseases , 2005, Nature Genetics.

[6]  I. Thompson,et al.  Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. , 2009, Carcinogenesis.

[7]  Rajiv Dhir,et al.  Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway , 2006, Molecular Cancer.

[8]  J. Blangero,et al.  Interactions Between Variants in the β3-Adrenergic Receptor and Peroxisome Proliferator–Activated Receptor-γ2 Genes and Obesity , 2001 .

[9]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[10]  Bhramar Mukherjee,et al.  Exploiting Gene‐Environment Independence for Analysis of Case–Control Studies: An Empirical Bayes‐Type Shrinkage Estimator to Trade‐Off between Bias and Efficiency , 2008, Biometrics.

[11]  Zijie Sun,et al.  Roles and regulation of Wnt signaling and β-catenin in prostate cancer , 2006 .

[12]  P S Albert,et al.  Limitations of the case-only design for identifying gene-environment interactions. , 2001, American journal of epidemiology.

[13]  B. Morgan,et al.  Negative Score Test Statistic , 2007 .

[14]  David V Conti,et al.  Detecting gene-environment interactions using a combined case-only and case-control approach. , 2008, American journal of epidemiology.

[15]  A. Nicolucci.  Epidemiological aspects of neoplasms in diabetes , 2010, Acta Diabetologica.

[16]  K. Żukowski,et al.  Degradation of basement membrane by prostate tumor heparanase. , 1999, The Journal of surgical research.

[17]  D. Gudbjartsson,et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.

[18]  J. Tukey.  One Degree of Freedom for Non-Additivity , 1949 .

[19]  Gary D Bader,et al.  Global Mapping of the Yeast Genetic Interaction Network , 2004, Science.

[20]  Z. Werb,et al.  Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. , 2005, Neoplasia.

[21]  Ian Chambers,et al.  Estrogen-Related Receptor Beta Interacts with Oct4 To Positively Regulate Nanog Gene Expression , 2008, Molecular and Cellular Biology.

[22]  Peter Kraft,et al.  Exploiting Gene-Environment Interaction to Detect Genetic Associations , 2007, Human Heredity.

[23]  Zijie Sun,et al.  Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. , 2006, Cancer letters.

[24]  D. Reich,et al.  Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus , 2009, PLoS genetics.

[25]  W. Gauderman,et al.  Gene-environment interaction in genome-wide association studies. , 2008, American journal of epidemiology.

[26]  T. van Wezel,et al.  Four new colon cancer susceptibility loci, Scc6 to Scc9 in the mouse. , 1999, Cancer research.

[27]  Chawnshang Chang,et al.  Differential Regulation of Direct Repeat 3 Vitamin D3and Direct Repeat 4 Thyroid Hormone Signaling Pathways by the Human TR4 Orphan Receptor* , 1999, The Journal of Biological Chemistry.

[28]  J. Blangero,et al.  Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity. , 2001, Diabetes care.

[29]  Juliet M Chapman,et al.  Detecting association using epistatic information , 2007, Genetic epidemiology.

[30]  N. Chatterjee,et al.  Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. , 2006, American journal of human genetics.

[31]  T. Thin,et al.  Convergence of two repressors through heterodimer formation of androgen receptor and testicular orphan receptor-4: a unique signaling pathway in the steroid receptor superfamily. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Jack A. Taylor,et al.  Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. , 1994, Statistics in medicine.

[33]  R. Nawroth,et al.  Extracellular Sulfatases, Elements of the Wnt Signaling Pathway, Positively Regulate Growth and Tumorigenicity of Human Pancreatic Cancer Cells , 2007, PloS one.

[34]  P. Stattin,et al.  Obesity, Endogenous Hormone Metabolism, and Prostate Cancer Risk: A Conundrum of “Highs” and “Lows” , 2010, Cancer Prevention Research.

[35]  Nilanjan Chatterjee,et al.  Semiparametric maximum likelihood estimation exploiting gene-environment independence in case-control studies , 2005 .

[36]  Yang Liu,et al.  Genome-Wide Interaction-Based Association Analysis Identified Multiple New Susceptibility Loci for Common Diseases , 2011, PLoS genetics.

[37]  YU KAI,et al.  Efficient p-value evaluation for resampling-based tests , 2011 .

[38]  D. Freedman.  How Can the Score Test Be Inconsistent? , 2007 .

[39]  Gary G. Schwartz,et al.  UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States) , 2006, Cancer Causes & Control.

[40]  A. Hart,et al.  Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. , 2001, Journal of the National Cancer Institute.

[41]  E. Mariman,et al.  Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing , 2006, Diabetologia.

[42]  V. Gnanapragasam,et al.  Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype , 2010, The Journal of pathology.

[43]  W D Flanders,et al.  Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! , 1996, American journal of epidemiology.

[44]  The unit of selection in Drosophila mercatorum. I. The interation of selection and meiosis in parthenogenetic strains. , 1976, Genetics.

[45]  Fei Zou,et al.  Assessing genomewide statistical significance in linkage studies , 2004, Genetic epidemiology.

[46]  T. Frayling,et al.  A genetic link between type 2 diabetes and prostate cancer , 2008, Diabetologia.

[47]  S. Thorgeirsson,et al.  Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma , 2008, Hepatology.

[48]  John L Hopper,et al.  Multiple loci with different cancer specificities within the 8q24 gene desert. , 2008, Journal of the National Cancer Institute.

[49]  R. Sanderson,et al.  HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor Growth in Vivo* , 2005, Journal of Biological Chemistry.

[50]  K. Conde-Knape.  Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications , 2001, Diabetes/metabolism research and reviews.

[51]  G Parmigiani,et al.  Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer , 2008, Oncogene.

[52]  D. Jablons,et al.  Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis , 2009, Oncogene.

[53]  David M. Evans,et al.  Two-Stage Two-Locus Models in Genome-Wide Association , 2006, PLoS genetics.

[54]  S. Kerje,et al.  A global search reveals epistatic interaction between QTL for early growth in the chicken. , 2003, Genome research.

[55]  Peter Kraft,et al.  Identification of a new prostate cancer susceptibility locus on chromosome 8q24 , 2009, Nature Genetics.

[56]  G. Satten,et al.  Inference on haplotype effects in case-control studies using unphased genotype data. , 2003, American journal of human genetics.

[57]  R. Pyke,et al.  Logistic disease incidence models and case-control studies , 1979 .

[58]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[59]  D. Zeng,et al.  Likelihood-Based Inference on Haplotype Effects in Genetic Association Studies , 2006 .

[60]  W. Willett,et al.  Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. , 2011, Cancer research.

[61]  H. Morris,et al.  Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. , 2002, Annual review of nutrition.

[62]  C. Carlberg,et al.  Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. , 2001, Frontiers in bioscience : a journal and virtual library.

[63]  Peter Kraft,et al.  Using principal components of genetic variation for robust and powerful detection of gene-gene interactions in case-control and case-only studies. , 2010, American journal of human genetics.

[64]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[65]  M. Ittmann,et al.  The role of fibroblast growth factors and their receptors in prostate cancer. , 2004, Endocrine-related cancer.

[66]  J. Cheverud,et al.  AN EPISTATIC GENETIC BASIS FOR FLUCTUATING ASYMMETRY OF MANDIBLE SIZE IN MICE , 2002, Evolution; international journal of organic evolution.

[67]  B. Pierce,et al.  Genetic Susceptibility to Type 2 Diabetes Is Associated with Reduced Prostate Cancer Risk , 2010, Human Heredity.